Sean P. Nolan - Chief Executive Officer, Director at Taysha Gene Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
TSHA on Nasdaq
All Insider Reports
All Insider Reports

Sean P. Nolan - trading volume in the past year for Taysha Gene Therapies, Inc.

Holdings reported by Sean P. Nolan for Taysha Gene Therapies, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,908,257 $13,407,064 $4.61 26 Jan 2026 Direct
Common Stock 1,535,545 $8,445,497 $5.50 23 Jan 2026 Indirect
Employee Stock Option (right to buy) 648,000 12 Jan 2026 Direct Common Stock

Transactions reported by Sean P. Nolan for Taysha Gene Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.